Cerrahpaşa Medical Journal
ORIGINAL ARTICLE

Effect of nicotinamide on doxorubicin induced experimental cardiotoxicity

1.

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Histoloji ve Embriyoloji Anabilim Dalı, İstanbul

2.

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Tıbbi Biyoloji ve Genetik Anabilim Dalı, İstanbul

3.

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Halk Sağlığı Anabilim Dalı, İstanbul

4.

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Deney Hayvanları Araştırma Laboratuvarı, İstanbul

5.

Avrasya Hospital Patoloji Bölümü, İstanbul

Cerrahpasa Med J 2008; 39: 7-14
DOI: 10.2399/ctd.08.007
Read: 1602 Downloads: 536 Published: 20 July 2014

Objectives: We investigated the morphologic changes showing cardiotoxicity caused by use of the doxorubicin which is an antineoplastic agent, and the protective effect of nicotinamide.

Methods: We assigned thirty Wistar Albino male rats were randomly to four groups: Group 1 (Control) had %0.9 NaCl for 7 days, group 2 had Nicotinamide 200 mg/kg/day for 7 days, group 3 had single dose injection of Doxorubicin (20 mg/kg), group 4 had combination of Doxorubicin and Nicotinamide intraperitoneally. At the end of the experiment, the hearts were removed for light and electron microscopic investigations. We determined the tissue activites of catalase, glutathione-S-transferase, glutathione, glutathione peroxidase.

Results: Control and Nicotinamide rats showed a normal heart tissue morphology. The rats in group 3 exhibited disorganization of the myocardial fibres, and infiltration of inflammatory cells. The rats in group 4 displayed a significant decrease in morphological damage, with the disappearance of inflammatory cell infiltration.

Conclusion: Our findings suggested that the use of antioxidants of Nicotinamide may help to reduce Doxorubicin cardiotoxicity, thus contributing to clinical applications.

Files
EISSN 2687-1904